BridgeBio Pharma, Inc. (NASDAQ: BBIO) on Sunday presented data from the ATTRibute-CM study. The study showed that acoramidis ...

An international study surveying microbiome scientists found that when it comes to data reuse, a universal set of ethical ...

Could experiencing devastating floods, widespread wildfires, or record-breaking heatwaves be linked to the way people perceive climate action? Do people in different countries attribute these events ...

Joining USAA on the list of the four most-trusted banks are Chime, a fintech company that partners with FDIC-insured banks; Capital One Bank, part of Capital One Financial (COF); and Chase Bank, owned ...

Large language models (LLMs) have revolutionized the AI landscape, demonstrating remarkable capabilities across a wide range ...

Cases of valley fever, a fungal disease caused by spores found within soil in parts of the U.S., has been rising in recent decades, prompting warnings from local health authorities.

The Federal Drive with Terry Gerton provides expert insights on current events in the federal community. Read more interviews to keep up with daily news and analysis that affect the federal workforce.

Attorneys general secured a court order blocking the Trump administration's request for SNAP beneficiary data.

Modern data aggregators cross-match manufacturer build sheets ... insurers may deny coverage and investigators struggle to attribute liability. The ripple effect undercuts manufacturers’ ...

Generative AI is transforming search, but data hasn’t caught up. Learn which metrics exist and why the most valuable are ...

PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...